Thrombolysis in the Treatment of Acute Ischaemic Stroke: What are the Likely Pharmacoeconomic Consequences?

Author： Lindsberg P.J.   Roine R.O.   Kaste M.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.14, Iss.1, 2000-07, pp. : 1-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low-Flow Anaesthesia: Does it have Potential Pharmacoeconomic Consequences?

By Suttner S.   Boldt J.  

PharmacoEconomics, Vol. 17, Iss. 6, 2000-06 ,pp. : 585-590

Adis International

Access to resources Recommend Favorite

Thrombolytic Therapy for Acute Ischaemic Stroke: What Can We Do to Improve Outcomes?

By Demchuk Andrew M.  

Drugs, Vol. 72, Iss. 14, 2012-10 ,pp. : 1833-1845

Adis International

Access to resources Recommend Favorite

Venomous solution to acute ischaemic stroke?

By  

Inpharma, Vol. 1, Iss. 1238, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Thrombolysis in Acute Ischaemic Stroke: A Guide to Patient Selection

By Lindley Richard I.  

CNS Drugs, Vol. 19, Iss. 6, 2005-01 ,pp. : 539-551

Adis International

Access to resources Recommend Favorite

Neuroprotection and thrombolysis: combination therapy in acute ischaemic stroke

By Ly John V   Zavala Jorge A   Donnan Geoffrey A  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. : 1571-1581

Informa Healthcare

Access to resources Recommend Favorite